APRE
Aprea Therapeutics
$0.49
−$0.04 (−8.18%)Oct 29, 2026
Key metrics
The numbers that frame APRE today
- Market cap
- $6.22M
- Gross margin
- 100%
- ROIC
- 515.7%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.41
- 52wk High
- $1.49
Growth
Revenue and earnings trend for APRE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about APRE
Is Aprea Therapeutics a good buy?
No. Aprea Therapeutics has poor quality and mixed momentum. The setup is weak overall. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of APRE?
Aprea Therapeutics's market capitalization is $6.22M.
What is the 52-week high for APRE stock?
The 52-week high for Aprea Therapeutics is $1.49. The current close of $0.49 is 66.8% below that high.
What is the 52-week low for APRE stock?
The 52-week low for Aprea Therapeutics is $0.41. The current close of $0.49 is 20.5% above that low.
Does APRE stock pay dividends?
Aprea Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for APRE?
Aprea Therapeutics's Debt / Equity ratio is 0.